Summary:
- This article discusses a new study published in the journal Science that investigates the potential use of gene editing technology to treat Huntington's disease, a rare and fatal genetic disorder.
- The study demonstrates that using CRISPR-Cas9 gene editing to correct the mutant huntingtin gene in mouse models can significantly improve the symptoms and delay the progression of Huntington's disease.
- The researchers believe this approach could be a promising avenue for developing a potential cure or treatment for Huntington's disease, and they are now planning to conduct further studies to assess the safety and efficacy of this gene editing approach in human patients.